These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28768917)

  • 1. Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure.
    Momomura SI; Saito Y; Yasumura Y; Yamamoto K; Sakata Y; Daimon M; Kinugawa K; Okamoto H; Dohi N; Komuro I
    Circ J; 2017 Dec; 82(1):141-147. PubMed ID: 28768917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent/permanent atrial fibrillation (BISONO-AF study).
    Yamashita T; Ikeda T; Akita Y
    J Cardiol; 2019 May; 73(5):386-393. PubMed ID: 30591320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study.
    Matsuoka H; Kuwajima I; Shimada K; Mitamura H; Saruta T
    J Clin Hypertens (Greenwich); 2013 Nov; 15(11):806-14. PubMed ID: 24119112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study.
    Hori M; Nagai R; Izumi T; Matsuzaki M
    Heart Vessels; 2014 Mar; 29(2):238-47. PubMed ID: 23559359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head comparison of the heart rate variability between the bisoprolol transdermal patch and bisoprolol fumarate tablet.
    Sairaku A; Nakano Y; Shiode N; Suenari K; Oda N; Ono K; Kihara Y
    Cardiovasc Ther; 2018 Jun; 36(3):e12325. PubMed ID: 29464917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension.
    Kiuchi S; Hisatake S; Kabuki T; Oka T; Dobashi S; Fujii T; Sano T; Ikeda T
    Clin Exp Hypertens; 2020 Aug; 42(6):539-544. PubMed ID: 32009474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy.
    Imori Y; Takano H; Mase H; Matsuda J; Sangen H; Izumi Y; Tokita Y; Yamamoto T; Shimizu W
    BMC Cardiovasc Disord; 2019 Dec; 19(1):316. PubMed ID: 31888491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.
    Nozaki A; Kobayashi T; Naruhashi K; Okugawa H; Horiuchi N; Nakanishi H; Kobayashi Y; Nakamura S
    Am J Emerg Med; 2021 Jan; 39():146-150. PubMed ID: 33039223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Optimization of use of beta-adrenoblockers in the treatment of chronic heart failure in the outpatient setting].
    Zhubrina ES; Ovchinnikov AG; Seredenina EM; Patrusheva IF; Blankova ZN; Kuz'mina AE; Kheĭmets GI; Ageev FT
    Ter Arkh; 2009; 81(11):35-40. PubMed ID: 20141011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
    Lainscak M; Podbregar M; Kovacic D; Rozman J; von Haehling S
    Respir Med; 2011 Oct; 105 Suppl 1():S44-9. PubMed ID: 22015086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching from carvedilol to bisoprolol ameliorates adverse effects in heart failure patients with dizziness or hypotension.
    Taniguchi T; Ohtani T; Mizote I; Kanzaki M; Ichibori Y; Minamiguchi H; Asano Y; Sakata Y; Komuro I
    J Cardiol; 2013 Jun; 61(6):417-22. PubMed ID: 23548374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease.
    Shinohara M; Fujino T; Koike H; Kitahara K; Kinoshita T; Yuzawa H; Suzuki T; Fukunaga S; Kobayashi K; Aoki J; Tanabe K; Ikeda T
    J Cardiol; 2017 Sep; 70(3):212-219. PubMed ID: 28343798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.
    Krum H; Bailey M; Meyer W; Verkenne P; Dargie H; Lechat P; Anker S
    Cardiology; 2007; 108(1):28-34. PubMed ID: 16960445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of bisoprolol 8mg transdermal patch at bedtime before coronary computed tomography angiography.
    Yamazaki D; Shimura Y; Enjoji Y; Nishinaga M; Kanmatuse K; Endo M
    J Cardiol; 2020 Apr; 75(4):394-399. PubMed ID: 31627998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical, hemodynamic and neurohumoral effects of switching patients with chronic heart failure from not recommended -adrenoblockers to bisoprolol in ambulatory practice].
    Ageev FT; Zhubrina ES; Ovchinnikov AG; Seredenina EM
    Kardiologiia; 2010; 50(6):41-7. PubMed ID: 20659026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial Effect on Surrogate Markers of Heart Failure with Bisoprolol Up-Titration to Recommended Targets in Korean Patients with Heart Failure and Left Ventricular Systolic Dysfunction.
    Han SW; Choi SW; Ryu KH; Kim HJ; Kim SH; Shim WJ; Cha TJ; Choi DJ; Kim YJ; Yoo BS; Kim JH; Hwang KK; Jeon H; Shin MS
    Cardiovasc Ther; 2016 Jun; 34(3):172-9. PubMed ID: 27003232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability, Efficacy, and Safety of Bisoprolol vs. Carvedilol in Japanese Patients With Heart Failure and Reduced Ejection Fraction　- The CIBIS-J Trial.
    Tsutsui H; Momomura SI; Masuyama T; Saito Y; Komuro I; Murohara T; Kinugawa S;
    Circ J; 2019 May; 83(6):1269-1277. PubMed ID: 30956267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching beta-blocker therapy in chronic heart failure.
    Tomcsányi J; Wettstein A; Toldy-Schedel E; Somlói M
    Int J Cardiol; 2008 Nov; 130(3):497-9. PubMed ID: 17707095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
    Nakamura K; Inokuchi R; Hiruma T; Tokunaga K; Doi K; Nakajima S
    J Anesth; 2016 Oct; 30(5):891-4. PubMed ID: 27262288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.